Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | DGKA | P23743 | 1/20 | 0.32 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL28531648 | 0.97 | TGFBR1 (0.35) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL28008059 | 0.86 | KDM4E (0.40) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL29055451 | 0.83 | KDM4E (0.35) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL26964423 | 0.83 | KDM4E (0.32) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL27484209 | 0.83 | LMNA (0.38) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL6064181 | 0.83 | KDM4E (0.32) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL221966 | 0.81 | KDM4E (0.35) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL28139213 | 0.81 | KDM4E (0.34) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL28284777 | 0.81 | KDM4E (0.34) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL27943440 | 0.81 | KDM4E (0.37) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240425742-A1 | High Temperature Suspension Additive For Wellbore Treatments | HALLIBURTON ENERGY SERVICES, INC. (US) | 2024-12-26 | — | — | US | claimed |
| CN-115605529-B | Photochromic polydiorganosiloxane vinyl cross-linking agent | 爱尔康公司 | 2024-03-26 | — | — | CN | claimed |
| CN-111919141-B | Silicone Hydrogel Contact Lenses | 爱尔康公司 | 2023-11-14 | — | — | CN | claimed |
| CN-109690360-B | Method for producing contact lenses having durable lubricious coatings thereon | 爱尔康公司 | 2023-04-25 | — | — | CN | claimed |
| CN-115698776-A | Insert material with high oxygen permeability coefficient and high refractive index | 爱尔康公司 | 2023-02-03 | — | — | CN | claimed |
| CN-115605529-A | Photochromic polydiorganosiloxane ethylene crosslinkers | 爱尔康公司（CH） | 2023-01-13 | — | — | CN | claimed |
| CN-115298573-A | High refractive index silicone insert materials for embedded contact lenses | 爱尔康公司 | 2022-11-04 | — | — | CN | claimed |
| CN-110709731-B | Silicone hydrogel contact lenses | 爱尔康公司 | 2022-05-24 | — | — | CN | claimed |
| US-20220059846-A1 | BATTERY WITH HALOGEN SEQUESTERING AGENT | GELION TECHNOLOGIES PTY LTD (AU) | 2022-02-24 | — | — | US | claimed |
| CN-110621483-B | Silicone hydrogel contact lenses | 爱尔康公司 | 2021-10-29 | — | — | CN | claimed |
| CN-110183973-A | A kind of solar battery imbrication component conducting resinl and preparation method thereof | 苏州柏特瑞新材料有限公司 | 2019-08-30 | — | — | CN | claimed |
| US-20160220503-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | ETH ZURICH (CH) | 2016-08-04 | — | — | US | claimed |
| US-20140186445-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | ETH ZURICH (CH) | 2014-07-03 | — | — | US | claimed |
| EP-2709601-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | ETH Zurich (CH) | 2014-03-26 | — | — | EP | claimed |
| CN-103507282-A | Method for manufacturing contact lens and contact lens | CHIANG KUO-CHING | 2014-01-15 | — | — | CN | claimed |
| WO-2012156065-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | ETH ZURICH (CH) | 2012-11-22 | — | — | WO | claimed |
| EP-2524690-A1 | Method for making customised nanoparticles, nanoparticles and use thereof | ETH Zurich (CH) | 2012-11-21 | — | — | EP | claimed |
| US-20090200692-A1 | Method for manufacturing a silicone contact lens having a hydrophilic surface | CHANG JAME | 2009-08-13 | — | — | US | claimed |
| EP-1468033-A1 | PHOSPHORUS-CONTAINING URETHANE (METH)ACRYLATE COMPOUNDS AND PHOTOSENSITIVE COMPOSITIONS | Showa Denko K.K. (JP) | 2004-10-20 | — | — | EP | claimed |
| WO-2003062296-A1 | PHOSPHORUS-CONTAINING URETHANE (METH)ACRYLATE COMPOUNDS AND PHOTOSENSITIVE COMPOSITIONS | SHOWA DENKO K. K. (JP) | 2003-07-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140186445-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | MSN, CD14, SAMM50 | LMNA 790/4885KDM4E 3672/4885DUSP3 3348/4885 |
| US-20160220503-A1 | METHOD FOR MAKING CUSTOMISED NANOPARTICLES, NANOPARTICLES AND USES THEREOF | MSN, CD14, SAMM50 | LMNA 790/4885KDM4E 3672/4885DUSP3 3348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.